KalVista Pharmaceuticals
KALV
KALV
26 hedge funds and large institutions have $51.3M invested in KalVista Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
7
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TI
Telemetry Investments
New York
|
+$447K |
| 2 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
+$178K |
| 3 |
SIM
Spark Investment Management
New York
|
+$108K |
| 4 |
BlackRock
New York
|
+$88.6K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$45.4K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.76M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$385K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$146K |
| 4 |
JPMorgan Chase & Co
New York
|
-$111K |
| 5 |
Renaissance Technologies
New York
|
-$62.5K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $1K | +$1K | +100 | New |
|
|
27
DZ Bank
Frankfurt Am Main,
Germany
| – | -$385K | -40,636 | Closed |
|
28
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$5K | -503 | Closed |
|